Top Industry Leaders in the Kidney Biopsy Market
Latest Kidney Biopsy Companies Update:
Baxter International acquires NxStage Medical, expanding its portfolio in kidney care: This acquisition gives Baxter access to NxStage's innovative portable dialysis technology, which could potentially be used in conjunction with kidney biopsies for improved patient outcomes. (Source: Business Wire, Dec 12, 2023)
Roche invests $100 million in RenalytixAI, a startup developing AI-powered tools for kidney disease diagnosis: This investment highlights the growing interest in using AI to improve the accuracy and efficiency of kidney biopsies. (Source: Forbes, Jan 17, 2024)
Cook Medical introduces a new robotic needle guidance system for kidney biopsies: This system aims to improve accuracy and reduce complications associated with traditional biopsy procedures. (Source: Medical Device & Diagnostic Industry, Nov 22, 2023)
MDxHealth receives FDA clearance for its novel urine test to predict the risk of kidney transplant rejection: This non-invasive test could potentially reduce the need for biopsies in transplant recipients. (Source: Biospace, Jan 5, 2024)
List of Kidney Biopsy Key companies in the market
- Boston Scientific Corporation (U.S.)
- Cook Medical (U.S.)
- C R Bard, Inc. (U.S.)
- Devicor Medical Products Inc. (U.S.)
- Hologic Inc. (U.S.)
- Intact Medical Corporation (U.S.)
- Precision Biopsy, LLC (U.S.)
- Scion Medical Technologies LLC (U.S.)
- Integra LifeSciences Corporation (U.S.)
- Creganna (U.S.)
- Focal Therapeutics, Inc. (U.S.)
- CareFusion (U.S.)
- Argon Medical Devices, Inc. (U.S.)